Effect of Sofosbuvir plus Ribavirin therapy on hepatitis C patients in Pakistan: a retrospective study

PeerJ
Zubia JamilAsghar A Durrani

Abstract

The annual global deaths from viral hepatitis is 1.4 million. Pakistan has the second highest burden of hepatitis C in the world. There is dire need to evaluate the response of new direct acting antivirals for the treatment of hepatitis C patients in Pakistan. World Health Organization has developed a strategy to treat 80% of HCV patients by 2030. In Pakistan, HCV treatment rate is 1%. The aim of the study was to analyze the effect of Sofosbuvir plus Ribavirin therapy on HCV patients in Pakistan. An observational study was conducted at Fauji Foundation Hospital Rawalpindi from November-2016 to July-2017. All the drugs were administered according to the guidelines of Asia Pacific Association for the Study of Liver (APASL) for the treatment of HCV patients. A total 327 chronic HCV patients were enrolled in the study and 304 completed the treatment. Patients belonged to three different groups including treatment: Naïve patients (n = 107), Non-Responder patients (n = 126) and patients who relapsed to Interferon therapy (n = 71). All the patients were given Sofosbuvir plus Ribavirin therapy for 24 weeks and the early virological response (EVR) and end treatment response (ETR) was calculated. Different parameters including patient ag...Continue Reading

References

May 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·S CrottyR Andino
Dec 5, 2009·World Journal of Gastroenterology : WJG·Yasir WaheedIshtiaq Qadri
Feb 15, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Hafsa AzizMuhammad Amin Athar
Jun 5, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hafsa AzizMuzaffar Lateef Gill
Jan 8, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Yasir WaheedMuhammad Ashraf
Oct 12, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donald B SmithPeter Simmonds
May 6, 2014·The New England Journal of Medicine·Stefan ZeuzemUNKNOWN VALENCE Investigators
Jul 30, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jane P MessinaEleanor Barnes
Nov 26, 2014·Journal of Pharmacology & Pharmacotherapeutics·Harmeet Kaur BhatiaNavreet Kaur Natt
May 6, 2015·Journal of Hepatology·Wahid DossGamal Esmat
May 1, 2016·Hepatology International·Masao OmataShiv Kumar Sarin

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
genotyping

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Mohammad Shoaib ShafiSyed Azmat Abbass
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Agha Babar HussainK A Karamat
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Javed Iqbal Farooqi, Rukhsana Javed Farooqi
© 2022 Meta ULC. All rights reserved